Ycanth Phase 3 Trial for Common Warts Doses First Patient
In Phase 2 (COVE-1), YCANTH (VP-102) achieved complete clearance of all treatable common warts at Day 84 in 51%...
Jon Napitupulu
Monte Rosa Presents New Interim MRT-8102 Phase 1 Results
Monte Rosa Therapeutics will present interim Phase 1 results for MRT-8102, a NEK7-directed molecular glue degrader, including data from...
Pridcor Long COVID Study Hits FDA & Publication Milestones
An observational case series published in Frontiers in Immunology reports sustained, patient-reported improvements in core Long COVID symptoms—fatigue, dysautonomia,...
New Hope in Trial for Difficult-to-Treat Pediatric Cancers
Two complete metabolic responses in relapsed/refractory metastatic Ewing sarcoma and one complete response in relapsed/refractory metastatic neuroblastoma headline the...
Ernexa’s Promising Cancer Trial Advances with FDA Success
Ernexa Therapeutics has completed a Pre-IND meeting with FDA and is targeting an IND submission to support a first-in-human...
Oxford, MDxHealth Validate GPS Test in Prostate Cancer Trial
More than 1,500 men with localized prostate cancer and over two decades of outcomes data from the UK ProtecT...
Sparrow Enrolls First Patient in Phase 2b Diabetes Trial
Sparrow Pharmaceuticals has enrolled the first patient in CAPTAIN-T2D, a double-blind Phase 2b study of clofutriben, an oral 11β-HSD1...
Taysha Reports Progress in Rett Syndrome Gene Therapy Study
Single-arm pivotal trial initiated in Q4 2025 is dosing 15 females with Rett syndrome (ages 6 to <22) with...
MindRank’s Promising AI Oral GLP-1 Enters Phase III Trial
MindRank’s Phase IIb data for MDR-001 showed a 10.3% mean weight reduction at Week 24 in 317 participants, with...
Alumis Reports Phase 3 Envudeucitinib Psoriasis Data
No efficacy or safety data yet. Alumis will release topline results from the Phase 3 ONWARD program of envudeucitinib,...